Ensysce Biosciences ENSC
NASDAQ ENSC
$0.51 -0.01 (-1.92%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Accumulated Expenses (2017 - 2021)

Updated

Ensysce Biosciences (ENSC) posted Accumulated Expenses of $411,941 for Q2 2021.

Analysis

Ensysce Biosciences (ENSC) Accumulated Expenses (2017 - 2021) Analysis & Trends

At the end of FY2020, Ensysce Biosciences' Accumulated Expenses came in at $344,792.

  • Annual Accumulated Expenses shows a three-year compound annual growth rate of 104.0% (FY2017 to FY2020).
  • In prior years, Ensysce Biosciences' Accumulated Expenses was $8,640 in FY2018 (-78.7%) and $40,640 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Ensysce Biosciences 1.30 Mn -10.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 411,941.00
Dec 31, 2020 344,792.00
Dec 31, 2018 8,640.00
Sep 30, 2018 8,640.00
Jun 30, 2018 8,640.00
Mar 31, 2018 8,640.00
Dec 31, 2017 40,640.00
API Access

Ensysce Biosciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENSC&period=max&api_key=YOUR_API_KEY